# Anca Askanase

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anca-askanase/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,730 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 49 |
| i10-index | 135 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5084645574 |
| ORCID iD | 0000-0003-4597-5023 |
| Works | 315 |

## Researcher papers

- [Trial of Anifrolumab in Active Systemic Lupus Erythematosus](https://scholariq.org/papers/trial-of-anifrolumab-in-active-systemic-lupus-erythematosus/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [2021 DORIS definition of remission in SLE: final recommendations from an international task force](https://scholariq.org/papers/2021-doris-definition-of-remission-in-sle-final-recommendations-from-an/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [Cancer risk in systemic lupus: An updated international multi-centre cohort study](https://scholariq.org/papers/cancer-risk-in-systemic-lupus-an-updated-international-multi-centre-cohort-study/)
- [Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE](https://scholariq.org/papers/effect-of-belimumab-treatment-on-renal-outcomes-results-from-the-phase-3/)
- [Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block](https://scholariq.org/papers/immunohistologic-evidence-supports-apoptosis-igg-deposition-and-novel-macrophage/)
- [Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine](https://scholariq.org/papers/evaluation-of-the-risk-of-anti-ssa-ro-ssb-la-antibody-associated-cardiac/)
- [A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development](https://scholariq.org/papers/a-qualitative-analysis-of-patient-perspectives-and-preferences-in-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.